IGC Pharma (NYSEAMERICAN:IGC) Share Price Passes Above 200 Day Moving Average of $0.00

IGC Pharma, Inc. (NYSEAMERICAN:IGC)’s share price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.44. IGC Pharma shares last traded at $0.43, with a volume of 102,439 shares.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. StockNews.com assumed coverage on IGC Pharma in a research note on Monday, May 6th. They set a “sell” rating on the stock. Ascendiant Capital Markets reissued a “buy” rating and set a $3.25 price target on shares of IGC Pharma in a research note on Friday, June 21st.

IGC Pharma Stock Up 2.1 %

The company has a debt-to-equity ratio of 0.02, a current ratio of 1.58 and a quick ratio of 0.86. The company has a market capitalization of $32.83 million, a P/E ratio of -1.97 and a beta of 1.51.

IGC Pharma Company Profile

IGC Pharma, Inc, a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development.